Prostate Cancer Roundtable comments on USPSTF recommendation

Ten members of the Prostate Cancer Roundtable have today submitted a joint letter to the U.S. Preventive Services Task Force commenting on the recent draft recommendation of a “D” grade for use of the PSA test in screening for prostate cancer among men who do not have symptoms that are highly suspicious for prostate cancer, regardless of age, race, or family history. … READ MORE …

Non-ASTRO prostate cancer news reports: Thursday, November 5, 2009

Other news reports today — from sources not related to the ASTRO annual meeting — address such topics as:

  • Perceptions about the US Preventive Services Task Force recommendations regarding the use of PSA testing men men > 75 years
  • Renal insufficiency in men of long-term drug therapy for prostate cancer
  • Cetuximab + doxirubicin in the treatment of CRPC
  • The mechanism of action of estrogens in treatment of advanced prostate cancer … READ MORE …

“What would YOU do doctor?” A urologist’s take on the PSA controversy

If you want to read a flawless analysis of the problem every patient faces when the topic of prostate cancer screening comes up, beg, borrow, or steal a copy of an editorial in the August issue of the Journal of Urology, entitled “What Would You Do Doctor?” by Joseph Smith, MD. Sadly this editorial is not freely available on line. It should be! … READ MORE …

How GP/FPs think about PSA testing (in a nation with no guidelines)

The Republic of Ireland “is estimated to have one of the highest prostate cancer incidences in Europe,” but there are no clinical guidelines with respect to PSA testing.  The decision whether to test or not is therefore entirely up to individual general and family practitioners (known as “GPs” in Ireland), with — presumably — some degree of input from their patients. A new study has provided some interesting indications about how Ireland’s GPs think about PSA testing for their male patients. … READ MORE …